Cargando…

Evolution of functional antibodies following acute Epstein-Barr virus infection

While Epstein-Barr virus causes mostly asymptomatic infection, associated malignancies, and autoimmune and lymphoproliferative diseases occur. To dissect the evolution of humoral immune responses over the course of EBV infection and to gain a better understanding of the potential contribution of ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karsten, Christina B., Bartsch, Yannic C., Shin, Sally A., Slein, Matthew D., Heller, Howard M., Kolandaivelu, Kumaran, Middeldorp, Jaap M., Alter, Galit, Julg, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481173/ https://www.ncbi.nlm.nih.gov/pubmed/36067220 http://dx.doi.org/10.1371/journal.ppat.1010738

Ejemplares similares

Epstein-Barr–negative MS: a true phenomenon?
por: Dobson, Ruth, et al.
Publicado: (2017)

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
por: Hutajulu, Susanna Hilda, et al.
Publicado: (2014)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
por: Kuri, Ashvin, et al.
Publicado: (2020)

Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells
por: Rac, Jürgen, et al.
Publicado: (2015)

Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
por: Cizmeci, Deniz, et al.
Publicado: (2021)

BamHI-A rightward frame 1, an Epstein–Barr virus-encoded oncogene and immune modulator
por: Hoebe, Eveline K, et al.
Publicado: (2013)

A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
por: Karsten, Christina B., et al.
Publicado: (2019)

Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response
por: Dias, Michelle H. F., et al.
Publicado: (2022)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
por: Kaplonek, Paulina, et al.
Publicado: (2022)

Epstein-Barr Virus Antibodies in Kawasaki Disease
por: Lee, Soon-Ju, et al.
Publicado: (2006)

Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA
por: Correia, Samantha, et al.
Publicado: (2017)

Epstein–Barr virus in the multiple sclerosis brain: a controversial issue—report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
por: Lassmann, Hans, et al.
Publicado: (2011)

Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim
por: Paschos, Kostas, et al.
Publicado: (2009)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases
por: Correia, Samantha, et al.
Publicado: (2018)

Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study
por: Casabonne, Delphine, et al.
Publicado: (2015)

Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
por: Hoebe, Eveline, et al.
Publicado: (2018)

The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells
por: Lin, Xiaochen, et al.
Publicado: (2015)

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis
por: Meier, Ute-Christiane, et al.
Publicado: (2021)

Prognostic value of serum Epstein–Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein–Barr virus DNA
por: Yao, Ji‐Jin, et al.
Publicado: (2017)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Cytolytic virus activation therapy and treatment monitoring for Epstein‐Barr virus associated nasopharyngeal carcinoma in a mouse tumor model
por: Novalić, Zlata, et al.
Publicado: (2017)

Epstein‐Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin
por: Ramayanti, Octavia, et al.
Publicado: (2016)

Discrete SARS-CoV-2 antibody titers track with functional humoral stability
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma
por: Hutajulu, Susanna H, et al.
Publicado: (2010)

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
por: Escalante, Gabriela M., et al.
Publicado: (2020)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms
por: Bartsch, Yannic, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57s9ph3mkneoqsubhe386ea7uj